Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | TP53 |
| Variant | Y220S |
| Impact List | missense |
| Protein Effect | unknown |
| Gene Variant Descriptions | TP53 Y220S lies within the DNA-binding domain of the Tp53 protein (PMID: 22713868). Y220S is predicted to result in decreased Tp53 stability based on structural modeling (PMID: 31128451), but has not been biochemically characterized and therefore, its effect on Tp53 protein function is unknown (PubMed, Jun 2026). |
| Associated Drug Resistance | |
| Category Variants Paths |
TP53 mutant TP53 exon6 TP53 Y220S |
| Transcript | NM_000546.6 |
| gDNA | chr17:g.7674872T>G |
| cDNA | c.659A>C |
| Protein | p.Y220S |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_001407270.1 | chr17:g.7674872T>G | c.659A>C | p.Y220S | RefSeq | GRCh38/hg38 |
| NM_000546.6 | chr17:g.7674872T>G | c.659A>C | p.Y220S | RefSeq | GRCh38/hg38 |
| NM_001126112.2 | chr17:g.7674872T>G | c.659A>C | p.Y220S | RefSeq | GRCh38/hg38 |
| NM_000546 | chr17:g.7674872T>G | c.659A>C | p.Y220S | RefSeq | GRCh38/hg38 |
| NM_000546.5 | chr17:g.7674872T>G | c.659A>C | p.Y220S | RefSeq | GRCh38/hg38 |
| NM_001407266.1 | chr17:g.7674872T>G | c.659A>C | p.Y220S | RefSeq | GRCh38/hg38 |
| NM_001126113.2 | chr17:g.7674872T>G | c.659A>C | p.Y220S | RefSeq | GRCh38/hg38 |
| NM_001126112.3 | chr17:g.7674872T>G | c.659A>C | p.Y220S | RefSeq | GRCh38/hg38 |
| NM_001126112 | chr17:g.7674872T>G | c.659A>C | p.Y220S | RefSeq | GRCh38/hg38 |
| NM_001126113 | chr17:g.7674872T>G | c.659A>C | p.Y220S | RefSeq | GRCh38/hg38 |
| NM_001407262.1 | chr17:g.7674872T>G | c.659A>C | p.Y220S | RefSeq | GRCh38/hg38 |
| NM_001126114 | chr17:g.7674872T>G | c.659A>C | p.Y220S | RefSeq | GRCh38/hg38 |
| NM_001407268.1 | chr17:g.7674872T>G | c.659A>C | p.Y220S | RefSeq | GRCh38/hg38 |
| NM_001126113.3 | chr17:g.7674872T>G | c.659A>C | p.Y220S | RefSeq | GRCh38/hg38 |
| NM_001407264.1 | chr17:g.7674872T>G | c.659A>C | p.Y220S | RefSeq | GRCh38/hg38 |
| NM_001126114.3 | chr17:g.7674872T>G | c.659A>C | p.Y220S | RefSeq | GRCh38/hg38 |
| NM_001126114.2 | chr17:g.7674872T>G | c.659A>C | p.Y220S | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| TP53 Y220S | Advanced Solid Tumor | decreased response | Rezatapopt | Preclinical - Cell culture | Actionable | In a preclinical study, Rezatapopt (PC14586) reactivated Tp53 function, inhibited proliferation, viability and colony formation, and induced cell cycle arrest and apoptosis in cells expressing TP53 Y220S with reduced potency compared to TP53 Y220C in culture (PMID: 41748563). | 41748563 |